Oppenheimer Maintains Outperform on Itron, Raises Price Target to $135
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Noah Kaye maintains Itron (NASDAQ:ITRI) with a Outperform and raises the price target from $133 to $135.
Oppenheimer analyst Noah Kaye maintains Itron (NASDAQ:ITRI) with a Outperform and raises the price target from $133 to $135.